Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein

M Carlsson1, L Eriksson, I Erwander

  • 1Department of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden. malin.carlsson@njur.lu.se

Abstract

Insights

Autoantibodies against bactericidal permeability increasing protein (BPI-ANCA) are linked to lung damage in cystic fibrosis (CF) patients, particularly those with Pseudomonas aeruginosa colonization. BPI-ANCA presence indicates more severe lung disease.

Area of Science:

  • Immunology
  • Pulmonology
  • Infectious Disease

Background:

  • Lung damage is a primary cause of mortality in cystic fibrosis (CF), driven by bacterial infections and inflammation.
  • Autoantibodies against bactericidal permeability increasing protein (BPI-ANCA) have been recently identified in CF patients.

Purpose of the Study:

  • To confirm the association between BPI-ANCA and CF.
  • To assess the relationship between BPI-ANCA, total IgG levels, bacterial colonization, pulmonary function, and musculoskeletal symptoms in CF patients.

Main Methods:

  • Measurement of BPI-ANCA, MPO-ANCA, and PR3-ANCA using ELISA in 46 adult CF patients.
  • Determination of total IgG levels via immunoturbidimetry.
  • Correlation analysis of ANCA and IgG levels with bacterial colonization, lung function (FEV1), and musculoskeletal symptoms.

Main Results:

  • BPI-ANCA was detected in 33 out of 46 patients.
  • Both BPI-ANCA and total IgG showed an inverse correlation with lung function in the overall group.
  • In patients with chronic Pseudomonas aeruginosa colonization, BPI-ANCA alone was significantly correlated with lung damage (p=0.01).
  • Median FEV1 was 43% in P. aeruginosa colonized patients with high BPI-ANCA versus 83% in those without BPI-ANCA.

Conclusions:

  • Lung damage induced by P. aeruginosa in CF patients is associated with the presence of BPI-ANCA.
  • CF patients colonized with P. aeruginosa but lacking BPI-ANCA exhibit near-normal lung function.
  • BPI-ANCA may serve as a biomarker to differentiate CF patients with severe lung damage from those with less destructive disease.
  • No association was found between ANCA and vasculitis-like or musculoskeletal symptoms in CF.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: